A detailed history of Vicus Capital transactions in Abb Vie Inc. stock. As of the latest transaction made, Vicus Capital holds 3,347 shares of ABBV stock, worth $567,751. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,347
Previous 3,015 11.01%
Holding current value
$567,751
Previous $517,000 27.66%
% of portfolio
0.06%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$163.84 - $199.33 $54,394 - $66,177
332 Added 11.01%
3,347 $660,000
Q2 2024

Jul 23, 2024

BUY
$154.79 - $180.76 $114,235 - $133,400
738 Added 32.41%
3,015 $517,000
Q1 2024

Apr 17, 2024

SELL
$159.82 - $182.1 $62,809 - $71,565
-393 Reduced 14.72%
2,277 $414,000
Q4 2023

Feb 01, 2024

SELL
$137.6 - $154.97 $116,272 - $130,949
-845 Reduced 24.04%
2,670 $413,000
Q3 2023

Oct 23, 2023

BUY
$133.59 - $154.65 $15,362 - $17,784
115 Added 3.38%
3,515 $523,000
Q2 2023

Aug 17, 2023

SELL
$132.51 - $164.9 $172,395 - $214,534
-1,301 Reduced 27.67%
3,400 $458,000
Q1 2023

May 02, 2023

SELL
$144.61 - $166.54 $171,941 - $198,016
-1,189 Reduced 20.19%
4,701 $749,000
Q4 2022

Feb 15, 2023

SELL
$138.31 - $165.87 $248,958 - $298,566
-1,800 Reduced 23.41%
5,890 $952,000
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $112,333 - $128,839
837 Added 12.21%
7,690 $1.03 Million
Q2 2022

Aug 10, 2022

BUY
$137.62 - $174.96 $100,600 - $127,895
731 Added 11.94%
6,853 $1.05 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $6,071 - $7,532
-46 Reduced 0.75%
6,122 $992,000
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $662,628 - $838,416
6,168 New
6,168 $855,000
Q2 2021

Aug 10, 2021

SELL
$105.21 - $117.21 $662,823 - $738,423
-6,300 Closed
0 $0
Q1 2021

May 04, 2021

BUY
$102.3 - $112.62 $4,398 - $4,842
43 Added 0.69%
6,300 $682,000
Q4 2020

Feb 01, 2021

SELL
$80.49 - $108.67 $47,891 - $64,658
-595 Reduced 8.68%
6,257 $670,000
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $9,364 - $10,990
109 Added 1.62%
6,852 $600,000
Q2 2020

Aug 03, 2020

BUY
$73.37 - $98.18 $40,500 - $54,195
552 Added 8.92%
6,743 $662,000
Q1 2020

May 07, 2020

SELL
$64.5 - $97.79 $139,642 - $211,715
-2,165 Reduced 25.91%
6,191 $472,000
Q4 2019

Feb 04, 2020

SELL
$72.13 - $90.25 $194,823 - $243,765
-2,701 Reduced 24.43%
8,356 $740,000
Q3 2019

Nov 18, 2019

BUY
$62.98 - $75.72 $25,821 - $31,045
410 Added 3.85%
11,057 $837,000
Q2 2019

Aug 08, 2019

BUY
$65.7 - $83.98 $139,152 - $177,869
2,118 Added 24.83%
10,647 $774,000
Q1 2019

May 02, 2019

SELL
$77.14 - $90.79 $7,328 - $8,625
-95 Reduced 1.1%
8,529 $687,000
Q4 2018

Feb 07, 2019

SELL
$77.85 - $96.01 $11,210 - $13,825
-144 Reduced 1.64%
8,624 $795,000
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $15,914 - $17,692
-179 Reduced 2.0%
8,768 $829,000
Q2 2018

Aug 02, 2018

SELL
$89.78 - $106.23 $67,424 - $79,778
-751 Reduced 7.74%
8,947 $829,000
Q1 2018

May 07, 2018

SELL
$92.01 - $123.21 $269,037 - $360,266
-2,924 Reduced 23.17%
9,698 $918,000
Q4 2017

Jan 25, 2018

SELL
$89.56 - $98.21 $95,202 - $104,397
-1,063 Reduced 7.77%
12,622 $1.22 Million
Q3 2017

Oct 27, 2017

BUY
$69.85 - $89.22 $955,897 - $1.22 Million
13,685
13,685 $1.22 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Vicus Capital Portfolio

Follow Vicus Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vicus Capital, based on Form 13F filings with the SEC.

News

Stay updated on Vicus Capital with notifications on news.